CYTOKINETICS, INCORPORATED Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
CYTOKINETICS, INCORPORATED (CYTK) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $188.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-02-26
- CYTOKINETICS, INCORPORATED unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $188.00K, a 93.81% increase from fiscal 2024.
- CYTOKINETICS, INCORPORATED unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $97.00K, a 0.00% change from fiscal 2023.
- CYTOKINETICS, INCORPORATED unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $97.00K, a 94.62% decline from fiscal 2022.
- CYTOKINETICS, INCORPORATED unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $1.80M, a 6120.69% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $188.00K 10-K · filed 2026-02-26 |
| 2024-12-31 | $97.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $97.00K 10-K · filed 2026-02-26 |
| 2022-12-31 | $1.80M 10-K · filed 2025-02-27 |
| 2021-12-31 | $29.00K 10-K · filed 2024-02-28 |
| 2020-12-31 | $3.00K 10-K · filed 2023-03-01 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-25 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-26 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-07 |
| 2016-12-31 | $5.00K 10-K · filed 2018-03-05 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-06 |
| 2014-12-31 | $85.00K 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |